O P CHAINS LTD Q4 RESULTS
Apollo Hospitals shares rise 4% after reporting 83% YoY jump in Q1 PAT. Should you buy?
Apollo Hospitals Share Price: Apollo Hospitals' stock saw a 4.2% increase after reporting a Q1 FY25 net profit of Rs 305 crore, up from Rs 167 crore last year. Revenue grew by 15% to Rs 5,086 crore. Several brokerage firms maintained positive ratings, highlighting improvements in occupancy and revenue segments.
Allcargo Logistics Q1 Results: Net profit plummets 97% to Rs 3.36 crore
Allcargo Logistics Q1 Results: Allcargo Logistics' standalone net profit fell drastically by 97% to Rs 3.36 crore in Q1, compared to Rs 198.26 crore last year. However, their income from operations increased by 46%. Growth in their contract logistics and international supply chain has been noted. They expect continued demand through the year's peak season.
Vodafone Idea Q1 preview: Subscriber losses, flat ARPU to dent revenue prospects
Vodafone Idea is expected to report a flat revenue for the quarter that ended June 30 owing to losses in the subscriber base coupled with a flattish Average Revenue Per User (ARPU) according to estimates by four brokerages.
Metropolis Q1 results: Net profit rises 31% to Rs 38 crore
The earnings for interest, tax, depreciation and ammortisation (EBITDA) before CSR and ESOP rose 20.2% YoY to Rs 80.5 crore in Q1. The EBITDA margin in Q1FY25 was 25%.
Alkem Labs Q1 Results: Net profit zooms 90% to Rs 545 crore
The company reported Rs 287 crore in the corresponding quarter of the previous year. Revenue from operations grew 2.2% y-o-y to Rs 3032 crore in Q1FY25.
Wockhardt Q1 Results: Net loss narrows to Rs 16 crore
The Mumbai-based drug maker reported a net loss of Rs 136 crore in Q1FY25. Revenue rose 14% year-on-year (y-o-y) to Rs.747 crore in Q1FY25 compared to Rs.658 crore in Q4FY24.
- Go To Page 1
Grasim Q1 Results: Firm reports Rs 52 cr standalone loss versus Rs 355 cr yr-ago profit
Grasim experienced a Rs 52.12 crore standalone loss in the June 2024 quarter, falling from a Rs 355 crore profit a year ago. Revenue grew 11% YoY to Rs 6,894 crore, driven by its diversified businesses. However, the chemicals segment saw a revenue decrease. Grasim shares were up 1.17% to Rs 2,574.45 on NSE.
Grasim Industries Q1 preview: Revenue uptick seen at 17-25% YoY, PAT may fall on losses in VSF, paints biz
Grasim Industries' net profit for Q1 ending June 30, 2024, is projected to be between Rs 104 crore and Rs 231 crore, with revenue expected to see a 17%-25% YoY increase. However, losses in the VSF and paints segments are likely to pull down the PAT figures, compounded by weak operating margins.
Maersk Q2 Results: Profit drops 45% to $833 million over disruptions in global supply chains
The Red Sea crisis has led to increased operating costs for Maersk, it said, necessitating rerouted shipping lanes that have impacted the company's overall profitability. Despite this, Maersk’s revenue for the quarter was $12,771 million, slightly down from $12,988 million reported a year earlier.
Godrej Consumer Q1 Results: Cons PAT jumps 41% YoY to Rs 451 crore, revenue rises 8%
The company said that consolidated net profit without exceptional items and one-offs grew by 14% year-on-year, while EBITDA grew by 13%. The home care category grew at 8% YoY, personal care at 6% yoy, the total branded category at 7% yoy, and the unbranded and exports category at 121% yo-y. The total net sales increased by 9% y-o-y to Rs 2,140 crore.
NSE Q1 Results: Cons PAT rises 39% YoY to Rs 2,567 crore, revenue jumps 51%
NSE Q1 Results: Revenue from operations for the reported quarter stood at Rs 4,510 crore. The net profit margins for Q1 FY25 were 52%. During this quarter, the bourse allocated an additional Rs 587 crore to enhance the Core Settlement Guarantee Fund (SGF) corpus, raising it to Rs 10,500 crore as recommended by SEBI. After this contribution, the core SGF corpus will stand at Rs 9,726 crore.
Q1 results today: Godrej Consumer among 158 companies to announce earnings on Wednesday
Q1 results today: As the first quarter earnings season progressed, 158 companies, such as Pidilite, Godrej Consumer, NHPC, BSE, and ABFRL, announced their results. Godrej Consumer was projected to show a 46% increase in net profit but a slight dip in revenue. Kotak Securities highlighted growth in domestic volume and various categories.
Delhivery Q1 Results: Company swings to black, posts Rs 54 crore profit, revenue jumps 12% YoY
Delhivery Q1 Results Q1FY25: Its revenue from services jumped 12.6% year-on-year (YoY) to Rs 2,172 crore, up from Rs 1,930 crore in the same quarter of the previous year. | Quarterly Reports Latest News
Lower fuel cracks, tepid global demand and new refineries impacted Reliance's core O2C business: Mukesh Ambani
Reliance Industries' Q1 profit dropped to Rs 15,138 crore, a 5% year-on-year and 20% quarter-on-quarter decline from March's Rs 18,951 crore. The O2C segment experienced a 14.3% EBITDA fall due to lower fuel and petrochemical margins. Petrol margins decreased by 30%, depreciation was Rs 13,596 crore, and finance costs rose despite telecom and retail gains.
RIL Q1 results preview: Revenue may grow by 7-12% YoY, PAT could decline up to 6.3% on weak O2C
Reliance Industries is anticipated to report Q1FY25 profit between Rs 14,999 crore to Rs 19,084 crore with revenue estimates ranging from Rs 2,31,463 crore to Rs 2,22,254 crore. Concerns arise over O2C impact on earnings due to declining refining margins.
Avenue Supermarts shares jump 4%. Should you buy, sell, or hold after Q1 results?
Avenue Supermarts' shares surged 4% to Rs 5,166 on BSE as Q1 revenue rose 19% YoY, driven by 14% area expansion and 4% productivity growth. Analysts highlight narrowing gaps in revenue per sq ft (up 4.2% YoY) and per store (up 4.7% YoY), signaling higher share from larger stores.
Apollo Hospitals Q4 Results: Net profit soars 77% YoY to Rs 258 crore; revenue jumps 15%
Apollo Hospitals Q4 Results: Revenue from operations for the January-March 2024 period increased 15% YoY to Rs 4,944 crore. The company's board has recommended a final dividend of Rs 10 per share for FY24. EBITDA for the fourth quarter stood at Rs 640 crore in the reporting March quarter, compared with Rs 488 crore in the same quarter a year earlier.
Apollo Hospitals Q4 results today: What to expect
Apollo Hospitals is expected to post healthy growth in core earnings for the quarter ended March 2024 due to improved ARPOB and Healthco operations. Analysts predict a 68% year-on-year growth in net profit for the fourth quarter.
Q4 results today: Apollo Hospitals among 895 companies to announce earnings on Thursday
Fourth quarter earnings season is wrapping up with 895 companies reporting results on Thursday. Investors keenly await Apollo Hospitals' results, expecting robust growth driven by improved ARPOB and HealthCo operations. Analysts predict up to a 68% YoY increase in net profit, with sales expected to rise by 13%.
EIH Limited Q4 Results: PAT jumps 169% YoY to Rs 247.6 crore
EIH Limited, the flagship company of The Oberoi Group has posted a profit of Rs 677.7 crore for financial year 2024, up 105.9% year on year. The luxury hotel chain posted revenues of Rs 2626 crore for fiscal year 2024, up 25.3% year on year.
TVS Supply Chain Solutions Q4 Results: Firm reports consolidated PAT of Rs 5.38 crore
TVS Supply Chain Solutions Ltd reported a profit after tax of Rs 5.38 crore for the quarter January-March 2024, with total income growing to Rs 2,433.06 crore from Rs 2,332.53 crore in the same quarter last year, but facing a consolidated net loss of Rs 90.49 crore for the year ending March 31, 2024.
Glenmark Pharma Q4 Results: Net loss widens to Rs 121 crore YoY
Glenmark Pharma Q4 Results: The rise in loss was on account of declining sales in the US and exceptional items. It had reported a net loss of Rs 34.5 crore in the corresponding quarter of the previous year. In FY24, Glenmark's consolidated revenue reached Rs. 11,813 crore, a 2% increase year-over-year. The company's EBITDA margin for the fiscal year was 10.1%, primarily due to a one-time impact on sales in the India business during the third quarter.
Grasim Q4 Results: Net profit jumps 39% YoY to Rs 1,908 crore; revenue rises 13%
Grasim Q4 Results: The net profit stood at Rs 1,369 crore in the last year quarter. Revenue from operations increased 13% year-on-year to Rs 37,727 crore in the reporting period, compared with Rs 4,873 crore in the corresponding period of previous year.
Metropolis Healthcare Q4 Results: Net profit rises 8% to Rs 36 crore
The diagnostic chain reported Rs 33.5 crore net profit in the corresponding quarter of the previous year. Revenue from operations grew by 11% YoY to Rs 313 crore.
Pre-market action: Here's the trade setup for today's session
"Overall, we expect markets to witness a gradual recovery. However, concerns regarding consistent FII selling, India VIX still above 20 levels, ongoing general election polling and the outcome could keep volatility higher," said Siddhartha Khemka, Head - Retail Research, Motilal Oswal Financial
Delhivery back in red for Q4; CEO Sahil Barua flags softness in online consumption
In a post-earnings analyst call, Delhivery CEO Sahil Barua said Sandeep Barasia, executive director and chief business officer of the company, will step down after almost a decade with the firm.
Delhivery Q4 Results: Loss narrows to Rs 69 crore; revenue rises 12% YoY
Delhivery Q4 Results: The logistics player registered 13% growth in its revenue for the financial year 2023-24, while its losses narrowed sharply to Rs 249 crore. The company's loss was at Rs 1,008 crore in FY23. EBITDA for the January-March quarter rose to Rs 46 crore versus just Rs 13 crore in the same quarter of last year.
GIFT Nifty rises 120 points; here's the trading setup for today's session
"We expect the market to consolidate in a broader range as the election polling progresses and the result season nears the end," said Siddhartha Khemka, Head - Retail Research, Motilal Oswal Financial
Dr Reddy's Q4 Results: Net profit jumps 36% YoY to Rs 1307 crore
Dr Reddy's has reported a 36% year-on-year jump in quarterly net profit, helped by increase in volumes of base business, new product launches, partially offset by price erosion in certain markets.
Load More
